Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 10 October 2022Found: cell activation responses such as anaph ylaxis, and no effect on fertility or embry o-fetal and post-natal
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the NHS has commissioned research into the potential impact of (a) Covid-19 and (b) Covid-19 vaccines on the (i) diagnosis and (ii) treatment of Mast Cell Activation Syndrome.
Answered by Will Quince
The Department commissions research through the National Institute for Health and Care Research (NIHR). Vaccines must be tested in a wide range of studies, including clinical trials to establish their efficacy and safety, and have a product licence, known as a “marketing authorisation” before they can be made available for widespread use in humans. Since the start of the COVID-19 pandemic, the NIHR has allocated over £110 million in funding for COVID-19 vaccine research that has included consideration of vaccine safety and robust monitoring of adverse reactions to COVID-19 vaccines.
The NIHR welcomes funding applications for research into any aspect of human health, including vaccine side effects.
Dec. 30 2024
Source Page: New Year Honours List 2025Found: Order of the British Empire Member of the Order of the British Empire Matilda ASANTE-OWUSU Sickle Cell
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022Found: Mast cell activation syndrome Germa ny Spontaneous (medically unconfirmed) This is a spontaneous
Mar. 05 2025
Source Page: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mitesFound: and differentiation of naïve CD4 T cells into T Helper Cell Type 2 (TH2).
Written Evidence May. 24 2023
Inquiry: Benefit levels in the UKFound: I cannot take showers due to Postural Orthostatic Tachycardia Syndrome (POTS) which means i have to
Fund increased research into MCAS, PoTS and EDS and improved patient care
- Final Signatures: 941
Mast cell activation syndrome (MCAS), Postural tachycardia syndrome (PoTS), Ehlers-Danlos syndromes (EDS) are chronic conditions that can be debilitating. However, too many people with these conditions don't receive the support they need. We want increased funding for research and patient care.
Found: Mast cell activation syndrome (MCAS), Postural tachycardia syndrome (PoTS), Ehlers-Danlos syndromes (
Jun. 13 2024
Source Page: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mitesFound: and differentiation of naïve CD4 T cells into T Helper Cell Type 2 (TH2).
Jun. 13 2024
Source Page: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]Found: and differentiation of naïve CD4 T cells into T Helper Cell Type 2 (TH2).
Jul. 20 2023
Source Page: Non-technical summaries granted in 2023Found: Down Syndrome)).